Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-61.64	-57.13	148.95
Graham Fair Price	119.18	10.89	4.97
PEG	-94.27	0.02	0.34
Price/Book	14.22	4.28	3.75
Price/Cash Flow	68.53	-291.38	-925.78
Prices/Earnings	-79.78	-12.22	60.45
Price/Sales	21.98	25.62	21.00
Price/FCF	68.53	-291.38	-925.78
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	6.97	0.55	0.52
Operating Margin	598.14	-0.49	0.07
ROA	429.97	-0.07	0.01
ROE	0.02	-0.09	464.96
ROIC	0.02	-0.10	383.38
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	-0.03	-77.53
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	1.70	-7.05	315.69
EPS QOQ	1.76	-6.23	253.08
FCF QOQ	-1.12	-2.36	-110.56
Revenue QOQ	-0.03	-0.13	-331.92
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	192.64	257.50	33.67
Days Sales Outstanding (DSO)	262.52	266.67	1.58
Inventory Turnover	0.47	0.35	-25.19
Debt/Capitalization	0.08	0.08	7.99
Quick Ratio	2.22	1.47	-33.71
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	8.41	7.76	-7.79
Cash	1.86	1.69	-9.33
Capex	-0.08	-0.06	23.93
Free Cash Flow	-0.03	-0.11	-234.65
Revenue	1.50	1.30	-13.65
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	3.63	2.56	-29.42
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-5.66	1.73	-69.35
Naive Interpretation	Member

06 - Financial Health · Bad

Rating